Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Rosa

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2007
TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenograftsVincenzo Damiano, Rosa Caputo, Sonia Garofalo, et al.
Breast Cancer Research : BCR|June 3, 2014
Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer modelsLuigi Formisano, Lucia Nappi, Roberta Rosa, et al.
Proceedings. Biological Sciences|November 24, 2017
Genome diversity in the Neolithic Globular Amphorae culture and the spread of Indo-European languagesFrancesca Tassi, Stefania Vai, Silvia Ghirotto, et al.
Breast Cancer Research : BCR|December 22, 2025
Retraction Note: Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer modelsLuigi Formisano, Lucia Nappi, Roberta Rosa, et al.
Brain : a Journal of Neurology|November 22, 2020
Dendritic pathology, spine loss and synaptic reorganization in human cortex from epilepsy patientsLaura Rossini, Dalia De Santis, Roberta Rosa Mauceri, et al.
Oncotarget|September 2, 2015
Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational statusLuigi Formisano, Valentina D'Amato, Alberto Servetto, et al.
International Journal of Molecular Sciences|November 9, 2017
Development of 1,2,3-Triazole-Based Sphingosine Kinase Inhibitors and Their Evaluation as Antiproliferative AgentsAngela Corvino, Roberta Rosa, Giuseppina Maria Incisivo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2012
Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer modelsRoberta Rosa, Roberta Marciano, Umberto Malapelle, et al.
British Journal of Cancer|April 26, 2017
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancersConcetta Di Mauro, Roberta Rosa, Valentina D'Amato, et al.
European Journal of Human Genetics : EJHG|January 18, 2019
A genetic perspective on Longobard-Era migrationsStefania Vai, Andrea Brunelli, Alessandra Modi, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2007
TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenograftsVincenzo Damiano, Rosa Caputo, Sonia Garofalo, et al.
Breast Cancer Research : BCR|June 3, 2014
Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer modelsLuigi Formisano, Lucia Nappi, Roberta Rosa, et al.
Proceedings. Biological Sciences|November 24, 2017
Genome diversity in the Neolithic Globular Amphorae culture and the spread of Indo-European languagesFrancesca Tassi, Stefania Vai, Silvia Ghirotto, et al.
Breast Cancer Research : BCR|December 22, 2025
Retraction Note: Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer modelsLuigi Formisano, Lucia Nappi, Roberta Rosa, et al.
Brain : a Journal of Neurology|November 22, 2020
Dendritic pathology, spine loss and synaptic reorganization in human cortex from epilepsy patientsLaura Rossini, Dalia De Santis, Roberta Rosa Mauceri, et al.
Oncotarget|September 2, 2015
Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational statusLuigi Formisano, Valentina D'Amato, Alberto Servetto, et al.
International Journal of Molecular Sciences|November 9, 2017
Development of 1,2,3-Triazole-Based Sphingosine Kinase Inhibitors and Their Evaluation as Antiproliferative AgentsAngela Corvino, Roberta Rosa, Giuseppina Maria Incisivo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2012
Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer modelsRoberta Rosa, Roberta Marciano, Umberto Malapelle, et al.
British Journal of Cancer|April 26, 2017
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancersConcetta Di Mauro, Roberta Rosa, Valentina D'Amato, et al.
European Journal of Human Genetics : EJHG|January 18, 2019
A genetic perspective on Longobard-Era migrationsStefania Vai, Andrea Brunelli, Alessandra Modi, et al.
Pageof 5